non-preserved sterile liquid formulation clinical trials

A randomized, double-blind, placebo-controlled proof-of-concept parallel group clinical trial to investigate the efficacy, safety and tolerability of weekly subcutaneous (SC) dosing of CK-0045 in participants with overweight / obesity and Type 2 diabetes

This study is testing a new medicine, CK-0045, for people who have both type 2 diabetes and are overweight. It aims to see if the medicine can help control blood sugar and improve other health markers over 16 weeks.